| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a01d7935508cbe002beb151d4efde669 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-198
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-223
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-277 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-198
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-223
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-277 |
| filingDate |
1999-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2001-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_257631de208324cee5b3fbb82fc59f80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c2a22c2c61e20c0ae232bdfcfc8f8fc2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d49a74083f662581cf613b074e983f9a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_850afa4de87648be8f87730f54e25d43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d47e89de74a39dd5e7b7eaec3bc8435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b2682e0061b6aac54966061c59106211
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d3302a281e43b6f0f3b79fc4e41445bd |
| publicationDate |
2001-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-6262302-B1 |
| titleOfInvention |
N-(aryl/heteroaryl/alkylacetyl) amino acid amides, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
| abstract |
Disclosed are compounds which inhibit beta-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed pharmaceutical compositions comprising a compound which inhibits beta-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006014729-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6964957-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6849650-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006014704-A1 |
| priorityDate |
1996-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |